33620 Results

People

  1. Ladanyi
    Ladanyi
  2. Giralt
    Giralt
  3. Motzer
    Motzer
  4. Reuter
    Reuter
  5. Perales
    Perales
  6. Scher
    Scher
  7. Zelenetz
    Zelenetz
  8. Berger
    Berger
  9. Al-Ahmadie
    Al-Ahmadie
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)
  7. Department of Pathology and Laboratory Medicine (5172)
  8. Surgery (4871)
  9. Sloan Kettering Institute Faculty (3826)
  10. Sloan Kettering Institute Postdocs (3612)
  1. "Meeting abstract"
Formats
  1. Meeting Abstract (33620)
Groups
  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)

More Groups

People
  1. Marc Ladanyi (641)
  2. Sergio Giralt (632)
  3. Robert Motzer (574)
  4. Victor Reuter (568)
  5. Miguel-Angel Perales (482)
  6. Howard Scher (463)

More People

Years
  1. 2025 (295)
  2. 2024 (1694)
  3. 2023 (1954)
  4. 2022 (2196)
  5. 2021 (1731)
  6. 2020 (1901)

More Years

Publications
  1. Journal of Clinical Oncology (6252)
  2. Blood (3939)
  3. Laboratory Investigation (1846)
  4. Cancer Research (1822)
  5. International Journal of Radiation Oncology, Biology, Physics (1643)
  6. Modern Pathology (1494)

More Publications

Publishers
  1. American Society of Clinical Oncology (6251)
  2. Elsevier Inc. (4694)
  3. American Society of Hematology (3939)
  4. American Association for Cancer Research (3045)
  5. Nature Publishing Group (2151)
  6. Oxford University Press (2096)

More Publishers

Results (33620)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Letermovir prophylaxis demonstrates high efficacy in adult cytomegalovirus (CMV) seropositive cord blood transplant (CBT) recipients: A comparison with pre-letermovir era CBT controls
    Meeting Abstract

    Lau, C.; Politikos, I.; Maloy, M. A.; Naputo, K.; Afuye, A.; Devlin, S. M.; Bhatt, V.; Giralt, S. A.; Jakubowski, A. A.; Papadopoulos, E. B.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Letermovir in allogeneic hematopoietic cell transplantation: Beyond the label
    Meeting Abstract

    Lin, A.; Maloy, M. A.; Bhatt, V.; DeRespiris, L.; Griffin, M.; Lau, C.; Proli, A. J.; Barker, J. N.; Shaffer, B. C.; Giralt, S. A.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Impact of pre-transplant measurable residual disease on relapse incidence and progression-free survival in older AML/MDS patients following allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Lin, R. J.; Elko, T. A.; Devlin, S. M.; Perales, M. A.; Papadopoulos, E. B.; Castro-Malaspina, H.; Gyurkocza, B.; Shaffer, B. C.; Tamari, R.; Tallman, M.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Safety and feasibility of chimeric antigen receptor T cell therapy after allogeneic stem cell therapy in relapsed/refractory B cell lymphomas
    Meeting Abstract

    Jain, T.; Sauter, C. S.; Shah, G. L.; Maloy, M. A.; Chan, J.; Scordo, M.; Avecilla, S. T.; Batlevi, Y.; Dahi, P. B.; Batlevi, C. W.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Ruxolitinib in combination with corticosteroids for the treatment of steroid-refractory acute graft-vs-host disease: Results from the phase 2 REACH1 trial
    Meeting Abstract

    Jagasia, M.; Ali, H.; Schroeder, M. A.; Shah, N. N.; Chen, Y. B.; Dawkins, F.; Arbushites, M.; Tian, C.; Perales, M. A.
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Barriers and outcomes of allogeneic stem cell transplant (alloSCT) for human T cell lymphotropic virus 1 (HTLV-1) associated adult T-cell lymphoma-leukemia (ATLL) in the United States (US) from a large cohort in a major tertiary center
    Meeting Abstract

    Adrianzen Herrera, D. A.; Vishnuvardhan, N.; Butler, M.; Shah, U. A.; Villaorduna, A. A.; Bachier Rodriguez, L.; Kornblum, N.; Derman, O.; Shastri, A.; Mantzaris, I.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Do cytogenetics predict likelihood to attain minimal residual disease (MRD) post autologous stem cell transplantation (SCT) in multiple myeloma (MM)?
    Meeting Abstract

    Jain, T.; Guerrero, C.; Kosiorek, H.; Butterfield, R.; Mountjoy, L.; Reeder, C.; Bergsagel, P. L.; Larsen, J. T.; Stewart, K.; Fonseca, R.
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Cytomegalovirus reactivation promotes CD8+ T cell subset recovery after unmodified allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Jain, T.; Cho, C.; Hilden, P.; Politikos, I.; Borrill, T.; Giralt, S. A.; Maslak, P.; O'Reilly, R. J.; van den Brink, M. R. M.; Perales, M. A.
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Microbiota injury in auto-HCT is frequent, occurs across geography, and is comparable to that observed in allo-HCT
    Meeting Abstract

    Khan, N.; Peled, J. U.; Gomes, A.; Devlin, S. M.; Rondon Clavo, C.; Clurman, A.; Slingerland, J.; Slingerland, A. E.; Maloy, M. A.; Sung, A. D.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • HLA-a*0101 allele is associated with increased risk of cutaneous acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
    Meeting Abstract

    Fonseca, M.; Jakubowski, A. A.; Devlin, S. M.; Young, J. W.; Fatmi, S.; Maloy, M. A.; Giralt, S. A.; Ponce, D. M.; Markova, A.
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save